SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-023017
Filing Date
2021-05-04
Accepted
2021-05-04 09:35:48
Documents
68
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q mcrb-10q_20210331.htm   iXBRL 10-Q 2518545
2 EX-31.1 mcrb-ex311_7.htm EX-31.1 10560
3 EX-31.2 mcrb-ex312_6.htm EX-31.2 10487
4 EX-32.1 mcrb-ex321_9.htm EX-32.1 7363
5 EX-32.2 mcrb-ex322_10.htm EX-32.2 8104
  Complete submission text file 0001564590-21-023017.txt   8078678

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA mcrb-20210331.xsd EX-101.SCH 51619
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE mcrb-20210331_cal.xml EX-101.CAL 47945
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mcrb-20210331_def.xml EX-101.DEF 138371
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE mcrb-20210331_lab.xml EX-101.LAB 402673
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mcrb-20210331_pre.xml EX-101.PRE 288338
11 EXTRACTED XBRL INSTANCE DOCUMENT mcrb-10q_20210331_htm.xml XML 1473709
Mailing Address 200 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 200 SIDNEY STREET CAMBRIDGE MA 02139 617 945 9626
Seres Therapeutics, Inc. (Filer) CIK: 0001609809 (see all company filings)

IRS No.: 274326290 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37465 | Film No.: 21886364
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences